Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex VS Neostigmine and Glycopyrrolate Reversal of Neuromuscular Relaxation After Bowel Resection
NCT06112353Phase 4Completed
- Sponsor
- University of California, Irvine
- Start
- Apr 2024
- Primary completion
- Mar 2026
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Sugammadex in neuromuscular blockade (NMB), sponsored by University of California, Irvine. Started Apr 2024; status: completed.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT06112353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06112353.